Largest health care pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 health care pharmaceutical companies ranked by total liabilities, at SGD 177.2B, ahead of Pfizer (SGD 156.8B) and Johnson & Johnson (SGD 152B). Figures as of 19 Nov 2026, 20:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieSGD 177.2B
- Median
- SGD 2.7B
- Combined market value
- SGD 6.4T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SGD 177.2B | SGD 646.1B | SGD 365.50 | 1.06% down | 25% up | ||
| 2 | PfizerPFE · Health Care | SGD 156.8B | SGD 202.7B | SGD 35.56 | 1.89% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | SGD 152B | SGD 827.9B | SGD 343.91 | 2.36% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | SGD 111B | SGD 1.56T | SGD 1,747.40 | 2.16% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | SGD 108.8B | SGD 421.3B | SGD 170.90 | 3.97% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SGD 92.4B | SGD 153.8B | SGD 75.26 | 2.17% down | 30% up | ||
| 7 | AstraZenecaAZN · Health Care | SGD 84.4B | SGD 350.5B | SGD 225.99 | 2.12% down | 1% up | ||
| 8 | NovartisNVS · Health Care | SGD 83.2B | SGD 368.5B | SGD 195.13 | 2.67% down | 25% up | ||
| 9 | SanofiSNY · Health Care | SGD 79B | SGD 142.8B | SGD 59.47 | 2.29% down | 4% down | ||
| 10 | GSKGSK · Health Care | SGD 77.4B | SGD 123.8B | SGD 61.77 | 1.55% down | 5% up | ||
| 11 | Novo NordiskNVO · Health Care | SGD 66.9B | SGD 220.5B | SGD 50.03 | 1.78% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | SGD 65.4B | SGD 88.6B | SGD 27.73 | 0.92% up | 51% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | SGD 43.8B | SGD 233B | SGD 134.54 | 0.31% down | 16% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 42.4B | SGD 58.7B | SGD 50.34 | 7.72% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | SGD 29B | SGD 29.4B | SGD 25.63 | 2.14% down | 99% up | ||
| 16 | GrifolsGRFS · Health Care | SGD 17.4B | SGD 7.2B | SGD 10.64 | 2.77% down | 0% up | ||
| 17 | ZoetisZTS · Health Care | SGD 15.7B | SGD 42.6B | SGD 104.75 | 5.23% down | 26% down | ||
| 18 | Royalty PharmaRPRX · Health Care | SGD 12.8B | SGD 50.3B | SGD 87.55 | 1.29% down | 79% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | SGD 12B | SGD 123.7B | SGD 1,195.88 | 2.08% down | 28% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 9.5B | SGD 19.4B | SGD 302.57 | 5.46% down | 41% up | ||
| 21 | GenmabGMAB · Health Care | SGD 9.1B | SGD 40.7B | SGD 66.04 | 0.31% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | SGD 9B | SGD 169.7B | SGD 669.50 | 3.38% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | SGD 8.8B | SGD 17.1B | SGD 34.14 | 0.99% down | 26% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SGD 5.4B | SGD 25.7B | SGD 191.73 | 0.64% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | SGD 4.9B | SGD 59B | SGD 516.27 | 0.97% down | 16% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | SGD 4.7B | SGD 9.6B | SGD 27.54 | 2.54% down | 90% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | SGD 4B | SGD 6.3B | SGD 75.51 | 2.94% down | 21% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | SGD 3.9B | SGD 5.8B | SGD 35.03 | 0.99% down | 63% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | SGD 3.9B | SGD 19.6B | SGD 100.70 | 0.06% down | 21% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 2.7B | SGD 16B | SGD 19.21 | 0.70% down | 8% up | ||
| 31 | CytokineticsCYTK · Health Care | SGD 2.7B | SGD 9.3B | SGD 66.42 | 0.19% up | 19% down | ||
| 32 | Ascendis PharmaASND · Health Care | SGD 2.1B | SGD 21.6B | SGD 328.76 | 5.84% down | 29% up | ||
| 33 | InsmedINSM · Health Care | SGD 2B | SGD 40.9B | SGD 186.38 | 20.45% up | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | SGD 1.9B | SGD 15.4B | SGD 79.49 | 0.18% up | 17% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 7.9B | SGD 55.96 | 0.50% up | 13% up | ||
| 36 | United TherapeuticsUTHR · Health Care | SGD 1B | SGD 31B | SGD 726.82 | 2.53% down | 22% up | ||
| 37 | Legend BiotechLEGN · Health Care | SGD 945M | SGD 4B | SGD 20.82 | 0.80% down | 41% down | ||
| 38 | AlkermesALKS · Health Care | SGD 862.4M | SGD 10.1B | SGD 59.85 | 1.10% down | 66% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 848.5M | SGD 11.8B | SGD 510.06 | 0.80% down | 27% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | SGD 776.9M | SGD 9.2B | SGD 174.95 | 1.08% up | 6% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | SGD 701.9M | SGD 7.4B | SGD 370.38 | 4.00% down | 50% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SGD 682.1M | SGD 8.1B | SGD 123.60 | 3.46% up | 34% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | SGD 633.4M | SGD 5.9B | SGD 61.73 | 4.88% down | 45% up | ||
| 44 | Roivant SciencesROIV · Health Care | SGD 537.7M | SGD 36.6B | SGD 50.49 | 0.93% up | 91% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | SGD 536.3M | SGD 12.7B | SGD 84.11 | 1.52% down | 117% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | SGD 389.1M | SGD 6.3B | SGD 36.09 | 0.47% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 271.5M | SGD 10.5B | SGD 150.80 | 1.92% down | 18% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 253.2M | SGD 9.5B | SGD 120.86 | 1.56% down | 129% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | SGD 243.9M | SGD 9.2B | SGD 83.90 | 4.17% down | 10% down | ||
| 50 | ABIVAXABVX · Health Care | SGD 185.1M | SGD 9.2B | SGD 104.65 | 3.35% down | 32% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | SGD 139.2M | SGD 5.2B | SGD 38.22 | 1.61% up | 168% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | SGD 119.2M | SGD 10.8B | SGD 13.55 | 0.10% down | 36% down | ||
| 53 | ErascaERAS · Health Care | SGD 91.7M | SGD 6.5B | SGD 18.43 | 3.71% up | 395% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SGD 80.8M | SGD 12B | SGD 126.43 | 3.52% down | 332% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | SGD 77.2M | SGD 11.2B | SGD 402.11 | 2.01% up | 86% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | SGD 69.1M | SGD 10.5B | SGD 161.25 | 1.82% down | 51% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | SGD 48.5M | SGD 6.2B | SGD 109.77 | 1.20% up | 108% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | SGD 39.2M | SGD 5.8B | SGD 53.07 | 0.68% down | 86% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | SGD 21.6M | SGD 8.6B | SGD 126.47 | 2.27% up | 255% up | ||
| 60 | Belite BioBLTE · Health Care | SGD 13M | SGD 8B | SGD 196.50 | 2.62% down | 43% up | ||
| 61 | VeradermicsMANE · Health Care | SGD 11.8M | SGD 6.7B | SGD 158.50 | 1.72% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2916 SGD).
Questions and answers
Which health care pharmaceutical companies rank first by total liabilities?
AbbVie (SGD 177.2B), Pfizer (SGD 156.8B) and Johnson & Johnson (SGD 152B) are the top three of the 61 health care pharmaceutical companies ranked by total liabilities as of 19 Nov 2026, 20:33 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total liabilities have a combined market value of SGD 6.4T as of 19 Nov 2026, 20:33 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.